Package Leaflet: Information for the User
Lyumjev 100 units/ml solution for injection in vial
insulin lispro
This medicinal product is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.
Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.
Contents of the pack
Lyumjev 100 units/ml solution for injection in vial contains the active substance insulin lispro. Lyumjev is used to treat diabetes mellitus in adults, adolescents, and children from 1 year of age. It is an insulin that is administered at mealtimes and acts more quickly than other medicines that contain insulin lispro. Lyumjev has components that speed up the absorption of insulin lispro by the body.
Diabetes is a disease in which the body does not produce enough insulin or does not use insulin effectively, resulting in effects such as high blood sugar levels. Lyumjev is an insulin used to treat diabetes by controlling blood sugar levels. Effective treatment of diabetes, with good blood sugar control, prevents long-term complications of diabetes.
Treatment with Lyumjev helps control blood sugar levels in the long term and prevents complications of diabetes. Lyumjev reaches its maximum effect between 1 and 3 hours after injection and lasts up to 5 hours. You should use Lyumjev when you start eating, or up to 20 minutes after starting a meal.
Your doctor may recommend using Lyumjev in addition to a long-acting or intermediate-acting insulin. Do not change your insulin unless your doctor tells you to.
Do not use Lyumjev
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before starting to use Lyumjev.
If you have vision problems, you will need the help of a trained person to inject.
A low blood sugar level can be serious and untreated hypoglycemia can even cause death.
Lyumjev starts to lower blood sugar more quickly than other insulins administered at mealtimes. If you experience hypoglycemia, you may notice it soon after a Lyumjev injection. If you frequently experience hypoglycemia or have difficulty recognizing the symptoms, please discuss this with your doctor or nurse. If your blood sugar levels are well controlled with your current insulin therapy or if you have had diabetes for a long time, you may not perceive the warning symptoms that alert you to the fact that your blood sugar is dropping too low. Later in this leaflet, the warning symptoms are listed. For more information on symptoms, please consult "Common problems of diabetes".
You must carefully plan when to eat, when to exercise, and how much you can do. You must also strictly monitor your blood sugar levels by performing frequent blood sugar tests.
Making changes in the type of insulin you use can cause your blood sugar to rise or fall too much.
You may need to increase the frequency of blood sugar tests if you are at risk of having low blood sugar levels. Your doctor may consider it necessary to make changes in the doses of other medicines you use to treat your diabetes.
Stopping insulin administration or not using enough insulin could cause high blood sugar levels (hyperglycemia) and diabetic ketoacidosis, which are serious disorders that can even cause death. For more information on symptoms, please consult "Common problems of diabetes".
You should rotate the injection site to avoid changes in the skin, such as lumps under the skin. Insulin may not work as well if it is injected into a swollen area (see "How to use Lyumjev"). Contact your doctor if you are currently injecting into a swollen area, before starting to inject into a different area. Your doctor may instruct you to check your blood sugar levels more closely and adjust your insulin or the dose of your other diabetes medications.
Children and adolescents
This medicinal product is not recommended for use in children under 1 year of age.
Other medicines and Lyumjev
Tell your doctor, nurse, or pharmacist if you are taking, have recently taken, or might take any other medicines. Some medicines affect your blood sugar levels, which may require a change in your insulin dose.
Your blood sugar level may decrease (hypoglycemia) if you take:
Your blood sugar level may increase (hyperglycemia) if you take:
Beta-blockers (used for high blood pressure, arrhythmias, or angina) may make it harder to recognize the warning signs of low blood sugar levels.
Using Lyumjev with alcohol
If you drink alcohol, your blood sugar levels may increase or decrease. Therefore, you may need to change the amount of insulin you use. You should check your blood sugar levels more frequently than usual.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor, nurse, or pharmacist before using this medicinal product. The amount of insulin you need usually decreases during the first 3 months of pregnancy and increases in the following 6 months. Once you have had your baby, your insulin requirements will probably return to what they were before pregnancy.
During breastfeeding, there are no restrictions on treatment with Lyumjev. If you are breastfeeding, you may need to adjust your insulin dose or diet.
Driving and using machines
Your ability to concentrate and react may be reduced if you experience hypoglycemia. Please consider this possible problem, taking into account all situations that may be a risk for you or others (e.g., driving a car or using machines). You should consult your doctor about the convenience of driving if you:
Lyumjev contains sodium
This medicinal product contains less than 1 mmol of sodium (23 mg) per dose; i.e., it is essentially "sodium-free".
Follow the instructions for administration of the medicinal product contained in this leaflet or as indicated by your doctor, pharmacist, or nurse. If you are in doubt, ask your doctor, pharmacist, or nurse.
They will have indicated exactly how much Lyumjev you should use, when to use it, and how often. They will also indicate how often you should visit your doctor.
You should always carry a spare insulin and another injection device in case you need it.
If you are blind or have reduced vision, you will need the help of a person to inject.
Your doctor may indicate that you use Lyumjev as well as a long-acting or intermediate-acting insulin. Inject them separately. Lyumjev must not be mixed with any other insulin.
When to inject Lyumjev
Lyumjev is an insulin that is administered at mealtimes. You should use Lyumjev when you start eating, or 1-2 minutes before eating; you also have the option of injecting up to 20 minutes after starting a meal.
How much insulin to use
Your doctor will determine the dose based on your blood sugar level and body weight and will explain to you:
Do not use Lyumjev
Where to inject Lyumjev
How to inject Lyumjev from a vial
Using Lyumjev in an insulin pump
After injection
If you are unsure how much you have injected, check your blood sugar level before deciding whether you need another injection.
If you use more Lyumjev than you should
If you inject too much Lyumjev, or are unsure how much you have injected, you may experience low blood sugar. Check your blood sugar level.
If your blood sugar level is low (hypoglycemia) and you can treat yourself, take glucose tablets, sugar, or drink a sugary drink. Then eat fruit, biscuits, or a snack, as your doctor or nurse has indicated, and take a rest. This usually helps to overcome a low blood sugar level or a mild insulin overdose. Check your blood sugar level again after 15-20 minutes until it stabilizes.
If you are unable to treat yourself (severe hypoglycemia) because you feel too dizzy, weak, confused, have difficulty speaking, loss of consciousness, or have a seizure, you may need treatment with glucagon. This can be administered by a person who knows how to use it. After being treated with glucagon, take glucose or sugar. If you do not respond to glucagon, you should go to the hospital or call the emergency services. Ask your doctor to inform you about glucagon.
Tell the people around you that you have diabetes. Tell them what the consequences of low blood sugar levels could be, including the risk of losing consciousness.
Tell them that if you become unconscious, they should do the following: lay you on your side to prevent you from choking, seek immediate medical attention, and do not give you anything to eat or drink, as you may choke.
If you forget to use Lyumjev
If you forget to use your insulin or use less than you should, or are unsure how much you have injected, your blood sugar level may become very high (hyperglycemia). Check your blood sugar level to decide if an insulin dose is needed. Resume your usual dosing schedule at the next meal.
If you stop using Lyumjev
Do not stop treatment or change your insulin unless your doctor tells you to. If you use less Lyumjev than you should, you may experience high blood sugar levels.
If high blood sugar levels (hyperglycemia) are not treated properly, they can be very serious and cause headache, nausea, vomiting, abdominal pain, dehydration, loss of consciousness, coma, and even death (see section 4).
Three simple measuresto reduce the risk of hypoglycemia or hyperglycemia are:
If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Low blood sugar level (hypoglycemia)is very common with insulin treatment (it can affect more than 1 in 10 people). It can be very serious. If your blood sugar level drops too low, you may lose consciousness. Severe hypoglycemia can cause brain damage and put your life at risk. If you have symptoms of low blood sugar, act immediatelyto increase your blood sugar level. See section 3 "If you use more Lyumjev than you should".
Allergic reactionsare common (they can affect up to 1 in 10 people). They can be serious and include the following symptoms:
|
|
|
|
|
|
If you have a severe allergic reaction(including anaphylactic shock) to insulin or any of the components of Lyumjev, stop using this medicine and contact emergency medical services immediately.
Other adverse effects include
Very common
Reactions at the infusion site. In some people, redness, pain, inflammation, or itching appears at the insulin infusion site. If you have reactions at the infusion site, talk to your doctor.
Common
Reactions at the injection site. In some people, redness, pain, inflammation, or itching appears at the insulin injection site. These reactions usually disappear within a few minutes to a few weeks without the need to interrupt Lyumjev. If you have reactions at the injection site, talk to your doctor.
Uncommon(can affect up to 1 in 100 people)
Skin changes at the injection site: If insulin is injected too frequently in the same spot, the fatty tissue can shrink (lipoatrophy) or become thicker (lipohypertrophy). Lumps under the skin can also occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis). Insulin may not work well if injected into a lumpy area. Change the injection site to help avoid these skin changes.
Other possible adverse effects
Swelling in the arms or ankles due to fluid retention (edema), especially at the beginning of insulin treatment or during a change in your diabetes medications.
Reporting adverse effects
If you experience any adverse effects, consult your doctor or pharmacist, even if they are possible adverse effects not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can help provide more information on the safety of this medicine.
Common diabetes problems
Low blood sugar
Low blood sugar (hypoglycemia) means you do not have enough sugar in your blood.
This can happen if:
See the section "If you use more Lyumjev than you should".
The first symptoms of low blood sugar usually appear quickly and include:
If you are not sure how to recognize the warning signs, avoid situations like driving a car, where you or others could be in danger if hypoglycemia occurs.
High blood sugar level(hyperglycemia) and diabetic ketoacidosis
The first symptoms of hyperglycemia are:
Hyperglycemia can lead to diabetic ketoacidosis. The first symptoms appear slowly, over many hours or several days. These symptoms include:
If you have any of these symptoms and high blood sugar, get medical help immediately.
See the section "If you forget to use Lyumjev".
Illness
If you are ill, especially if you have nausea or vomiting, the amount of insulin you need may vary. Even if you are not eating as usual, you still need to receive insulin.Have your urine or blood checked, follow the instructions given to you for these cases, and inform your doctor.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the label and carton. The expiration date is the last day of the month indicated.
Do not freeze.
Store in the outer packaging to protect from light.
Before first use
Store in the refrigerator (between 2°C - 8°C).
After first use
Do not store above 30°C.
Discard after 28 days even if some solution remains.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Lyumjev 100 units/ml solution for injection in vial
Appearance and package contents of the product
Lyumjev 100 units/ml solution for injection is a clear, colorless, aqueous solution in a vial. Each vial contains 1000 units (10 milliliters). It is available in packs of 1 vial, 2 vials, or a multipack of 5 packs of 1 vial. Not all presentations may be marketed.
Marketing authorization holder
Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Netherlands.
Manufacturer
Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France.
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Belgium/België/Belgien Eli Lilly Benelux S.A./N.V. Tel: + 32-(0)2 548 84 84 | Lithuania Eli Lilly Lietuva Tel: +370 (5) 2649600 |
Luxembourg/Luxemburg Eli Lilly Benelux S.A./N.V. Tel: + 32-(0)2 548 84 84 | |
Czech Republic ELI LILLY CR, s.r.o. Tel: + 420 234 664 111 | Hungary Lilly Hungária Kft. Tel: + 36 1 328 5100 |
Denmark Eli Lilly Danmark A/S Tel: +45 45 26 6000 | Malta Charles de Giorgio Ltd. Tel: + 356 25600 500 |
Germany Lilly Deutschland GmbH Tel: + 49-(0) 6172 273 2222 | Netherlands Eli Lilly Nederland B.V. Tel: + 31-(0) 30 60 25 800 |
Estonia Eli Lilly Nederland B.V. Tel: +372 6817 280 | Norway Eli Lilly Norge A.S. Tel: + 47 22 88 18 00 |
Greece ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ Α.Ε.Β.Ε. Tel: +30 210 629 4600 | Austria Eli Lilly Ges. m.b.H. Tel: + 43-(0) 1 711 780 |
Spain Dista S.A. Tel: + 34-91 663 50 00 | Poland Eli Lilly Polska Sp. z o.o. Tel: +48 22 440 33 00 |
France Lilly France Tel: +33-(0) 1 55 49 34 34 | Portugal Lilly Portugal - Produtos Farmacêuticos, Lda Tel: + 351-21-4126600 |
Croatia Eli Lilly Hrvatska d.o.o. Tel: +385 1 2350 999 | Romania Eli Lilly România S.R.L. Tel: + 40 21 4023000 |
Ireland Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 | Slovenia Eli Lilly farmacevtska družba, d.o.o. Tel: +386 (0) 1 580 00 10 |
Iceland Icepharma hf. Tel: + 354 540 8000 | Slovakia Eli Lilly Slovakia s.r.o. Tel: + 421 220 663 111 |
Italy Eli Lilly Italia S.p.A. Tel: + 39- 055 42571 | Finland Oy Eli Lilly Finland Ab Tel: + 358-(0) 9 85 45 250 |
Cyprus Phadisco Ltd Tel: +357 22 715000 | Sweden Eli Lilly Sweden AB Tel: + 46-(0) 8 7378800 |
Latvia Eli Lilly (Suisse) S.A Parstavnieciba Latvija Tel: +371 67364000 | United Kingdom (Northern Ireland) Eli Lilly and Company (Ireland) Limited Tel: + 353-(0) 1 661 4377 |
Date of last revision of this leaflet:
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/.
This information is intended only for healthcare professionals:
Lyumjev 100 units/ml is available in vials for intravenous administration if needed.
For intravenous use, Lyumjev should be diluted to concentrations of 0.1 to 1.0 units/ml in a 5% glucose solution or a 9 mg/ml (0.9%) sodium chloride solution. It is recommended to purge the system before starting the infusion to the patient. Compatibility has been demonstrated with ethylene/propylene copolymer bags and polyolefin bags with polyvinyl chloride.
Chemical and physical stability has been demonstrated for 14 days at 2-8°C and 20 hours at 20-25°C protected from light. From a microbiological point of view, the medicine should be used immediately. If not used immediately, the storage times during use and the conditions before use are the responsibility of the user and normally will not exceed 24 hours at 2-8°C, unless the dilution is made under controlled and validated aseptic conditions.